News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,686 Results
Type
Article (4862)
Company Profile (13)
Press Release (131809)
Multimedia
Podcasts (5)
Webinars (1)
Section
Business (27616)
Career Advice (84)
Deals (5364)
Drug Delivery (14)
Drug Development (18122)
Employer Resources (10)
FDA (4142)
Job Trends (2707)
News (56253)
Policy (5525)
Tag
2027 Pharm Country Standard (1)
Academia (429)
Accelerated approval (23)
ADA (14)
Adcomms (5)
Allergies (62)
Alliances (8260)
ALS (103)
Alzheimer's disease (521)
Antibody-drug conjugate (ADC) (235)
Approvals (4595)
Artificial intelligence (302)
ASCO (202)
Autoimmune disease (140)
Automation (28)
Bankruptcy (42)
Best Places to Work (2718)
Biosimilars (113)
Biotechnology (10)
Bladder cancer (133)
Brain cancer (29)
Breast cancer (413)
Cancer (3123)
Cardiovascular disease (225)
Career advice (75)
Career pathing (2)
CAR-T (103)
CDC (5)
Cell therapy (317)
Cervical cancer (29)
Clinical research (18497)
Collaboration (981)
Company closure (1)
Compensation (456)
Complete response letters (12)
COVID-19 (377)
CRISPR (39)
C-suite (444)
Cystic fibrosis (49)
Data (4028)
Decentralized trials (1)
Depression (33)
Dermatology (43)
Diabetes (192)
Diagnostics (1486)
Digital health (23)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (130)
Drug pricing (22)
Drug shortages (2)
Duchenne muscular dystrophy (111)
Earnings (12951)
Editorial (5)
Employer resources (9)
Events (19781)
Executive appointments (476)
FDA (5917)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (19)
Funding (698)
Gene editing (77)
Generative AI (18)
Gene therapy (236)
GLP-1 (232)
Government (694)
Grass and pollen (4)
Guidances (166)
Healthcare (3145)
Hematology (76)
HIV (45)
Huntington's disease (16)
IgA nephropathy (38)
Immunology and inflammation (62)
Immuno-oncology (53)
Indications (96)
Infectious disease (510)
Inflammatory bowel disease (70)
Inflation Reduction Act (4)
Influenza (45)
Intellectual property (89)
Interviews (8)
IPO (2684)
IRA (1)
Job creations (282)
Job search strategy (67)
JPM (4)
Kidney cancer (12)
Layoffs (32)
Leadership (1)
Legal (1088)
Liver cancer (46)
Longevity (8)
Lung cancer (564)
Lymphoma (232)
Machine learning (29)
Management (2)
Manufacturing (357)
MASH (82)
Medical device (2636)
Medtech (2683)
Mergers & acquisitions (3206)
Metabolic disorders (418)
mRNA (34)
Multiple sclerosis (86)
NASH (4)
Neurodegenerative disease (190)
Neuropsychiatric disorders (24)
Neuroscience (1129)
NextGen: Class of 2026 (916)
Non-profit (602)
Now hiring (1)
Obesity (135)
Opinion (20)
Ovarian cancer (98)
Pain (87)
Pancreatic cancer (127)
Parkinson's disease (165)
Partnered (6)
Patents (169)
Patient recruitment (299)
Peanut (20)
People (9323)
Pharmaceutical (8)
Pharmacy benefit managers (5)
Phase 1 (5052)
Phase 2 (7640)
Phase 3 (7199)
Pipeline (4084)
Policy (19)
Postmarket research (736)
Preclinical (1844)
Press Release (48)
Prostate cancer (166)
Psychedelics (2)
Radiopharmaceuticals (82)
Rare diseases (372)
Real estate (845)
Recruiting (2)
Regulatory (5796)
Reports (14)
Research institute (430)
Resumes & cover letters (16)
Rett syndrome (27)
RNA editing (4)
RSV (38)
Schizophrenia (59)
Series A (113)
Series B (101)
Service/supplier (2)
Sickle cell disease (47)
Special edition (1)
Spinal muscular atrophy (23)
Sponsored (13)
Startups (440)
Stomach cancer (11)
Supply chain (47)
Tariffs (3)
The Weekly (5)
Vaccines (255)
Venture capital (13)
Weight loss (68)
Women's health (47)
Date
Today (55)
Last 7 days (272)
Last 30 days (1237)
Last 365 days (12049)
2026 (5754)
2025 (12500)
2024 (9208)
2023 (7543)
2022 (11273)
2021 (12618)
2020 (11380)
2019 (8393)
2018 (6388)
2017 (6097)
2016 (5620)
2015 (6353)
2014 (4550)
2013 (3543)
2012 (3696)
2011 (3816)
2010 (3404)
Location
Africa (109)
Alabama (9)
Alaska (3)
Arizona (40)
Arkansas (8)
Asia (9543)
Australia (2267)
California (5585)
Canada (1153)
China (659)
Colorado (185)
Connecticut (295)
Delaware (259)
Europe (24437)
Florida (543)
Georgia (204)
Hawaii (3)
Idaho (12)
Illinois (502)
India (50)
Indiana (189)
Iowa (9)
Japan (356)
Kansas (18)
Kentucky (14)
Louisiana (18)
Maine (11)
Maryland (530)
Massachusetts (4087)
Michigan (94)
Minnesota (249)
Mississippi (2)
Missouri (98)
Montana (7)
Nebraska (2)
Nevada (69)
New Hampshire (31)
New Jersey (1698)
New Mexico (15)
New York (1352)
North Carolina (555)
North Dakota (5)
Northern California (2854)
Ohio (143)
Oklahoma (7)
Oregon (9)
Pennsylvania (744)
Puerto Rico (4)
Rhode Island (15)
South America (118)
South Carolina (14)
Southern California (2100)
Tennessee (85)
Texas (849)
United States (18619)
Utah (90)
Vermont (1)
Virginia (132)
Washington D.C. (18)
Washington State (362)
West Virginia (1)
Wisconsin (105)
Wyoming (1)
136,686 Results for "l oreal usa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
May 20, 2026
·
3 min read
Press Releases
Codexis to share RNA manufacturing advances at TIDES USA
April 29, 2026
·
2 min read
Press Releases
ASAHI INTECC USA ANNOUNCES DISTRIBUTION OF QXMEDICAL BOOSTING CATHETER
May 4, 2026
·
3 min read
Opinion
The real potential of PD-(L)1×VEGF bispecifics may be outside lung cancer
PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing through trials in lung cancer. But the potential of these drugs may be highest in cancers where angiogenesis and immune escape are tightly intertwined.
May 28, 2026
·
6 min read
·
Souro Chowdhury
Press Releases
ESTEVE’S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY
May 4, 2026
·
5 min read
Press Releases
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
April 20, 2026
·
3 min read
Press Releases
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
·
3 min read
Press Releases
Autonomix Medical to Present at LSI USA ’26
March 11, 2026
·
3 min read
Press Releases
Aclarion CEO Brent Ness to Attend LSI USA 2026
March 12, 2026
·
3 min read
Press Releases
Volta Medical Announces Activities at Heart Rhythm Society 2026 in Chicago, IL, USA
April 7, 2026
·
3 min read
1 of 13,669
Next
